Digital Library
Close Browse articles from a journal
 
<< previous    next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 25 of 100 found articles
 
 
  Dacomitinib (PF-00299804), a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor, demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro
 
 
Title: Dacomitinib (PF-00299804), a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor, demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro
Author: Zhu, Liancheng
Lopez, Salvatore
Bellone, Stefania
Black, Jonathan
Cocco, Emiliano
Zigras, Tiffany
Predolini, Federica
Bonazzoli, Elena
Bussi, Beatrice
Stuhmer, Zachary
Schwab, Carlton L.
English, Diana P.
Ratner, Elena
Silasi, Dan-Arin
Azodi, Masoud
Schwartz, Peter E.
Rutherford, Thomas J.
Santin, Alessandro D.
Appeared in: Tumor biology
Paging: Volume 36 (2015) nr. 7 pages 5505-5513
Year: 2015
Contents:
Publisher: Springer Netherlands, Dordrecht
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 25 of 100 found articles
 
<< previous    next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands